As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
Prof. Nicolas Barry-Delongchamps, Professor of Urology at Cochin Hospital and Principal Investigator of the VIOLETTE trial, will present the final results and one-year patients follow-up from the ...
The technology is available on the new MyLabE85 GTS Edition that will be showcased together with the brand new MyLabC30 GTS ...
URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
At ECR 2026, UII reaffirmed its AI development principles, which are anchored in clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiology knowledge into a ...
Esaote presents its new and innovative technology dedicated to urology: the exclusive Prostate Attention Map (PAM), now ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:00 AM EDTCompany ParticipantsMark Stolper - Executive VP ...
Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Dig ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results